Advisory board
Brings a wealth of experience in biomaterials, drug discovery, regenerative medicine and 3D cell culture
Dr Elias Pavlopoulos
Associate Director R&D, Regeneron Pharmaceuticals.
Over 25 years neuroscience experience spanning basic molecular research through to translational drug discovery projects in large pharma.
Specialty areas include dementia, ALS, Huntington’s Disease, multiple sclerosis and the molecular mechanisms underlying learning and memory.
Prof. Jennifer Elisseeff
Director, Translational Tissue Engineering Center, Johns Hopkins University.
Brings more than 20 years of experience spanning operational, clinical and scientific aspects of pharmaceutical research, development and commercialisation. Jennifer has executed multiple commercial transactions and has successfully taken a drug from discovery through to regulatory approval.
Angela Luttick
Executive VP, Commercial at 360biolabs, a BioAgilytix company
Angela Luttick is a virologist with more than 20 years of experience in the discovery, development and commercialisation of novel drugs. She is well accustomed to leading multidisciplinary teams and ensuring the integrity of key discovery-stage biological data for IND packages used in FDA submissions. Angela is a co-founder and Executive Vice President, Commercial at 360biolabs, where she leads business growth strategies for the company.